SCHEMBL9923880

SCHEMBL9923880

CCOC(=O)c1nc2ccccn2c1C1CCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.58
PTGS2 P35354 1/20 0.58
MAPK1 P28482 2/20 0.55
ALDH1A1 P00352 6/20 0.54
TSHR P16473 1/20 0.54
NTRK1 P04629 1/20 0.53
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PDE4A P27815 2/20 0.44
GAA P10253 3/20 0.44
KDM4E B2RXH2 2/20 0.44
PDE4B Q07343 1/20 0.44
PDE7A Q13946 1/20 0.44
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9893269 0.95 PTGS1 (0.60) PTGS1PTGS2MAPK1ALDH1A1TSHR
SCHEMBL872190 0.79 PTGS1 (0.68) PTGS1PTGS2MAPK1ALDH1A1TSHR
SCHEMBL1421022 0.78 PTGS1 (0.62) PTGS1PTGS2MAPK1ALDH1A1TSHR
SCHEMBL118200 0.77 PTGS1 (0.65) PTGS1PTGS2MAPK1ALDH1A1TSHR
SCHEMBL2447965 0.77 PTGS1 (0.65) PTGS1PTGS2MAPK1ALDH1A1TSHR
SCHEMBL23387882 0.77 PTGS1 (0.65) PTGS1PTGS2MAPK1ALDH1A1TSHR
SCHEMBL117699 0.77 PTGS1 (0.65) PTGS1PTGS2MAPK1ALDH1A1TSHR
SCHEMBL118913 0.77 PTGS1 (0.65) PTGS1PTGS2MAPK1ALDH1A1TSHR
SCHEMBL12441268 0.76 PTGS1 (0.64) PTGS1PTGS2MAPK1ALDH1A1TSHR
SCHEMBL31312607 0.76 PTGS1 (0.64) PTGS1PTGS2MAPK1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 PTGS1 347/4885PTGS2 439/4885MAPK1 716/4885
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 PTGS1 347/4885PTGS2 439/4885MAPK1 716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.